Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03208920 · ClinicalTrials.gov registry record · NA
Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair
A NA study of Abdominal Aortic Aneurysm and PAD, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT03208920: Completed NA study of Abdominal Aortic Aneurysm and PAD, sponsored by University of California, San Francisco.
NCT03208920 is a NA study of Abdominal Aortic Aneurysm and PAD that has completed, run by University of California, San Francisco. The registered enrollment target is 2 participants, below the 454-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03208920, a NA study of Abdominal Aortic Aneurysm and PAD, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if high-dose PUFA supplementation in patients undergoing EVAR for infra-renal AAA reduces the peri-operative inflammation.
Primary Outcome
Blunting of the peri-PVI inflammatory response as measured by the area under the curve (AUC) of the inflammatory biomarker high sensitivity C reactive protein (CRP)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Pro-Omega
- OTHER ProOmega Placebo
Study Locations (1)
California
- San Francisco Veteran Affairs Medical Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-08-28 |
| Phase | NA |
What the finished NCT03208920 record still lists
NCT03208920 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 454-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which Pro-Omega is the first listed.
NCT03208920 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03208920 about?
NCT03208920 is a clinical study titled "Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair". The purpose of this study is to determine if high-dose PUFA supplementation in patients undergoing EVAR for infra-renal AAA reduces the peri-operative inflammation.
What is the current status of trial NCT03208920?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2016-12. Estimated completion is 2018-08-28.
What conditions does trial NCT03208920 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm, PAD.
What interventions are being tested in trial NCT03208920?
The interventions under investigation include: Pro-Omega (DIETARY_SUPPLEMENT), ProOmega Placebo (OTHER).
Who is sponsoring clinical trial NCT03208920?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03208920 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03208920's enrollment target sits among peer trials
2 17th of 16 the lowest of 16 other Abdominal Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
RECRUITING · NA
-
Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques
RECRUITING · NA
-
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
RECRUITING · NA
-
3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair
ACTIVE NOT RECRUITING · NA
-
Post-Approval Study of the TREO Abdominal Stent-Graft System
ACTIVE NOT RECRUITING · NA
-
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia